Doctor profile · Federal record

Dr. Xylina Gregg, M.D.

Medical Oncology Physician (CMS: Medical Oncology) · Hematology & Oncology Physician · Salt Lake City, UT

  • NPI 1972554459
  • Accepts Medicare
  • MIPS 71.2 / 100 · 2023
  • 35 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3838 S 700 E, Suite 100
Salt Lake City, UT 841061466
(801) 269-0231
fax (801) 269-0304
Mailing address
1121 E 3900 S, Suite C-240
Salt Lake City, UT 841241214

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
October 10, 2016
Year of graduation
1991 — 35 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Utah #6011093-1205

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1972554459. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
30,158
Distinct HCPCS
10
Medicare allowed
$524,169
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 15,000 14 $1
J0185 Injection, aprepitant, 1 mg 5,590 16 $2
J1627 Injection, granisetron, extended-release, 0.1 mg 2,900 11 $6
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,965 13 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 970 33 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 627 195 $8
80053 Blood test, comprehensive group of blood chemicals 468 160 $10
99214 Established patient office or other outpatient visit, 30-39 minutes 429 182 $121
A9595 Piflufolastat f-18, diagnostic, 1 millicurie 342 36 $614
96372 Injection of drug or substance under skin or into muscle 158 43 $13

In context: peer comparison

Among 12 peers in this city , average services per provider: 627. This provider delivers 48× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,789
Transactions
58
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Cornerstone Specialty Network LLC 3 $1,650.00
Daiichi Sankyo Inc. 14 $1,384.96
Karyopharm Therapeutics Inc. 3 $253.00
Gilead Sciences, Inc. 5 $184.05
GENZYME CORPORATION 4 $174.30
PharmaEssentia USA Corporation 1 $133.00
Merck Sharp & Dohme LLC 7 $132.92
AstraZeneca Pharmaceuticals LP 7 $132.45
SOBI, INC 1 $125.00
Incyte Corporation 2 $117.71
Novartis Pharmaceuticals Corporation 4 $107.33
Genmab U.S., Inc. 2 $51.11
Stemline Therapeutics Inc. 2 $48.69
E.R. Squibb & Sons, L.L.C. 2 $44.56
BeiGene USA, Inc. 1 $32.04

By nature of payment

Food and Beverage
$1,841
Honoraria
$1,650
Consulting Fee
$1,199
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
630
Patients
169
Total drug cost
$2,300,360
Drug Type Claims Patients Total cost
Anastrozole Generic 240 78 $8,239
Tamoxifen Citrate Generic 76 31 $3,114
Hydroxyurea Generic 62 17 $2,784
Imbruvica (Ibrutinib) Brand 37 0 $597,759
Letrozole Generic 34 15 $1,099
Ibrance (Palbociclib) Brand 29 0 $453,275
Acyclovir Generic 24 0 $112
Tagrisso (Osimertinib Mesylate) Brand 21 0 $339,920
Dexamethasone Generic 19 0 $467
Prochlorperazine Maleate Generic 18 14 $266

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Xylina Gregg's medical specialty?
Dr. Xylina Gregg practices Medical Oncology Physician in Salt Lake City, UT.
Where does Dr. Xylina Gregg practice?
Dr. Xylina Gregg practices at 3838 S 700 E, Salt Lake City, UT 841061466. Office phone: 8012690231.
What is Dr. Xylina Gregg's NPI?
Dr. Xylina Gregg's National Provider Identifier (NPI) is 1972554459, issued by NPPES.
Does Dr. Xylina Gregg accept Medicare assignment?
Yes. Dr. Xylina Gregg accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Xylina Gregg commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, aprepitant, 1 mg (HCPCS J0185); Injection, granisetron, extended-release, 0.1 mg (HCPCS J1627). Source: CMS Medicare Physician & Other Practitioners file.